Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Tvardi Therapeutics, Inc.US flagNASDAQ Global Market
2.95
USD
-0.22
- -
27.67MMarket Cap

Income Statement (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
21
19
28
27
+ Selling, General & Admin
3
3
4
9
+ Research & Development
18
16
24
18
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-21
-19
-28
-27
- Non-Operating (Income) Loss
-1
-1
1
-9
+ Interest Expense, Net
-1
-1
-1
-1
+ Interest Expense
- -
- -
- -
- -
- Interest Income
1
1
1
1
+ Other Non-Op (Income) Loss
- -
- -
2
-7
Pretax Income
-21
-17
-29
-18
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-21
-17
-29
-18
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-21
-17
-29
-18
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-21
-17
-29
-18
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-21
-17
-29
-18
EBIT
-21
-19
-28
-27
EBITDA
-21
-19
-28
-27
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
-21
-19
-28
-27
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
3
3
3
7
Basic EPS, GAAP
-7.98
-6.74
-11.41
-2.46
Basic EPS from Cont Ops
-7.98
-6.74
-11.41
-2.46
Diluted Weighted Avg Shares
3
3
3
8
Diluted EPS, GAAP
-7.98
-6.74
-11.41
-2.34
Diluted EPS from Cont Ops
-7.98
-6.74
-11.41
-2.34

Balance Sheet (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
44
26
32
32
+ Cash, Cash Equivalents & STI
44
23
32
31
+ Cash & Cash Equivalents
21
23
32
21
+ ST Investments
22
- -
- -
10
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
3
- -
1
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
1
1
4
1
+ Property, Plant & Equip, Net
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
1
- -
3
- -
+ Total Intangible Assets
1
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
1
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
3
- -
Total Assets
45
27
35
32
+ Payables & Accruals
4
2
9
10
+ Accounts Payable
2
2
2
3
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
7
6
+ ST Debt
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
1
1
1
1
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
1
1
Total Current Liabilities
4
3
10
11
+ LT Debt
- -
- -
30
- -
+ LT Borrowings
- -
- -
30
- -
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
86
86
86
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
86
86
86
- -
Total Noncurrent Liabilities
86
86
116
- -
Total Liabilities
90
89
126
11
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
- -
1
1
131
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
1
131
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-45
-63
-92
-110
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-45
-62
-91
21
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-45
-62
-91
21
Total Liabilities & Equity
45
27
35
32
Shares Outstanding
9
9
9
9
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
Net Debt
-21
-23
-1
-21
Net Debt to Equity
47.7
36.93
1.49
-98.99
Tangible Common Equity Ratio
-102.19
-235.4
-262.87
64.96
Current Ratio
10.31
7.97
3.06
2.86
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-21
-17
-29
-18
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
2
-6
+ Stock-Based Compensation
- -
- -
- -
1
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
2
-7
+ Chg in Non-Cash Work Cap
3
-4
9
1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-3
3
- -
+ Inc (Dec) in Accts Payable
2
-1
6
1
+ Inc (Dec) in Other
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-18
-21
-18
-23
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
1
+ Increase in Capital Stock
- -
- -
- -
1
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
-22
22
- -
-10
+ Dec in LT Investment
22
22
- -
21
+ Inc in LT Investment
-44
- -
- -
-31
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-22
22
- -
-10
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
28
- -
+ Cash From Debt
- -
- -
28
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
-1
22
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
- -
- -
27
23
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
-40
1
9
-11
EBITDA
-21
-19
-28
-27
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
-18
-21
-18
-23
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-21
10
-23
Free Cash Flow per Basic Share
-6.96
-8.17
-7.11
-3.17
Price/Free Cash Flow
- -
- -
- -
-1.42
Cash Flow to Net Income
0.87
1.21
0.62
1.29
Capital Expenditures
- -
- -
- -
- -